Top Banner
Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute
62

Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Jan 16, 2016

Download

Documents

Norah Peters
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Medical Considerations for Manned Commercial Space Flight

Melchor Antuñano, M.D., M.S.Director, FAA Civil Aerospace Medical Institute

Medical Considerations for Manned Commercial Space Flight

Melchor Antuñano, M.D., M.S.Director, FAA Civil Aerospace Medical Institute

Page 2: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Ad Astra Magazine (Jan/Feb 2001 Issue)

“Some regulation of space access is probable, but it is critical to engage in frank discussion that takes into account a variety of viewpoints in order to create logical guidelines that will not completely prevent the public from being able to fly in space”

Ad Astra Magazine (Jan/Feb 2001 Issue)

“Some regulation of space access is probable, but it is critical to engage in frank discussion that takes into account a variety of viewpoints in order to create logical guidelines that will not completely prevent the public from being able to fly in space”

National Space Society (NSS)National Space Society (NSS)

Page 3: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Ad Astra Magazine (Jan/Feb 2001 Issue)

“Other short-term effects of spaceflight, such as skeletal and heart muscle weakening, bone loss, and radiation exposure are generally limited and are likely to pose minimal risk to an otherwise healthy space traveler. However, those with known heart disease, osteoporosis, or even cancer may be disqualified from space travel as the potential for worsening their medical conditions exists”

Ad Astra Magazine (Jan/Feb 2001 Issue)

“Other short-term effects of spaceflight, such as skeletal and heart muscle weakening, bone loss, and radiation exposure are generally limited and are likely to pose minimal risk to an otherwise healthy space traveler. However, those with known heart disease, osteoporosis, or even cancer may be disqualified from space travel as the potential for worsening their medical conditions exists”

National Space Society (NSS)National Space Society (NSS)

Page 4: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

In 1999 the Aerospace Medical Association (AsMA) approved the following resolution:

“The Aerospace Medical Association urges that appropriate agencies develop relevant U.S. Federal policies, procedures, guidelines, and regulations to ensure the health and safety of human crewmembers and passengers who will be involved in manned commercial space flights in the near future”

In 1999 the Aerospace Medical Association (AsMA) approved the following resolution:

“The Aerospace Medical Association urges that appropriate agencies develop relevant U.S. Federal policies, procedures, guidelines, and regulations to ensure the health and safety of human crewmembers and passengers who will be involved in manned commercial space flights in the near future”

AsMAAsMA

Page 5: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

On November 20, 2000, the Aerospace Medical Association convened a task force to develop a position paper on “Medical Guidelines for Space Passengers”

Guidelines were published in the “Aviation, Space and Environmental Medicine” journal in October 2001 and November 2002

On November 20, 2000, the Aerospace Medical Association convened a task force to develop a position paper on “Medical Guidelines for Space Passengers”

Guidelines were published in the “Aviation, Space and Environmental Medicine” journal in October 2001 and November 2002

AsMAAsMA

Page 6: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• Manned commercial space operations will include various types of RLVs with different flight envelopes

• It is reasonable to expect that here will be some form of regulatory oversight (national and international) of these activities

• It is very important to avoid excessive regulatory oversight that could interfere with the development of this emerging industry

• Manned commercial space operations will include various types of RLVs with different flight envelopes

• It is reasonable to expect that here will be some form of regulatory oversight (national and international) of these activities

• It is very important to avoid excessive regulatory oversight that could interfere with the development of this emerging industry

Page 7: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

The U.S. House of Representatives sent to the Senate the Commercial Space Launch Amendments Act of 2004 to promote the development of the commercial human space flight industry

The public interest is served by creating a clear legal and regulatory regime for commercial human space flight

Establishes “Experimental Permit” AST has sole authority over licensing of suborbital

vehicles Allows “informed consent” of the customer to accept the

risks of spaceflight

The U.S. House of Representatives sent to the Senate the Commercial Space Launch Amendments Act of 2004 to promote the development of the commercial human space flight industry

The public interest is served by creating a clear legal and regulatory regime for commercial human space flight

Establishes “Experimental Permit” AST has sole authority over licensing of suborbital

vehicles Allows “informed consent” of the customer to accept the

risks of spaceflight

February 2004February 2004

Page 8: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

The U.S. Senate has put on hold approval of this Act due to disagreements over how much protection to offer potential space travelers

The U.S. Senate has put on hold approval of this Act due to disagreements over how much protection to offer potential space travelers

October 2004October 2004

Page 9: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

“The greatest danger for most of us is not that our aim is too high and we miss it, but that it is too

low and we reach it”

Michelangelo

“The greatest danger for most of us is not that our aim is too high and we miss it, but that it is too

low and we reach it”

Michelangelo

Page 10: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

The problem is that we live in a litigious society where the safety of RLV occupants is likely to become an issue that the manned commercial space transportation industry will have to face sooner or later

The problem is that we live in a litigious society where the safety of RLV occupants is likely to become an issue that the manned commercial space transportation industry will have to face sooner or later

Page 11: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Reusable Launch Vehicles (RLV) represent the most feasible approach for the development and implementation of successful manned commercial space flights

Reusable Launch Vehicles (RLV) represent the most feasible approach for the development and implementation of successful manned commercial space flights

Page 12: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

FAA SUPPORT OF MANNED COMMERCIAL SPACE

OPERATIONSIN THE U.S.

FAA SUPPORT OF MANNED COMMERCIAL SPACE

OPERATIONSIN THE U.S.

Page 13: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Letter from the FAA Associate Administrator for AST

(October 8, 1998)

Public Safety Issues for Launch and Reentry Reusable Launch Vehicles (RLVs) and Reentry Vehicles (RVs)

Human rating safety requirements for RLVs (life support requirements, training and personnel qualifications, and functional responsibility for public safety-related operations)

Letter from the FAA Associate Administrator for AST

(October 8, 1998)

Public Safety Issues for Launch and Reentry Reusable Launch Vehicles (RLVs) and Reentry Vehicles (RVs)

Human rating safety requirements for RLVs (life support requirements, training and personnel qualifications, and functional responsibility for public safety-related operations)

Page 14: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

AST releases “Draft Guidelines for Licensed Suborbital RLV Operations with Flight Crew”

AST releases “Draft Guidelines for Licensed Suborbital RLV Operations with Flight Crew”

FAA Associate Administrator for AST

(October 2003)

FAA Associate Administrator for AST

(October 2003)

Page 15: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

CAMI is producing a report on “Minimum Environmental Control & Life Support Guidelines for Manned Commercial RLVs”

CAMI is producing a report on “Minimum Environmental Control & Life Support Guidelines for Manned Commercial RLVs”

FAA Office of Aerospace Medicine(August 2003 to present)

FAA Office of Aerospace Medicine(August 2003 to present)

Page 16: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 17: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• March 1998: The Federal Air Surgeon approved establishment of the Space Medicine Program Committee (SMPC) at the Civil Aerospace Medical Institute (CAMI)

• June 1998: The SMPC met at CAMI and established the Space Medical Certification Subcommittee (SMCS)

• April 1999: The SMCS produced a final draft on “Medical Standards for Orbital Commercial Space Flight Crews” that was submitted to the Federal Air Surgeon for review

• March 1998: The Federal Air Surgeon approved establishment of the Space Medicine Program Committee (SMPC) at the Civil Aerospace Medical Institute (CAMI)

• June 1998: The SMPC met at CAMI and established the Space Medical Certification Subcommittee (SMCS)

• April 1999: The SMCS produced a final draft on “Medical Standards for Orbital Commercial Space Flight Crews” that was submitted to the Federal Air Surgeon for review

FAA Office of Aerospace MedicineFAA Office of Aerospace Medicine

Page 18: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• June 1999: The SMPC produced a prioritized list of medical and human factors research needs in support of manned commercial space operations that was submitted to AST

• February 2000: The SMCS produced a final draft on “Recommended Guidelines for Medical Screening of Commercial Space Passengers” that was submitted to the Federal Air Surgeon and AST for review

• March 2003: The “Guidelines” were approved by the Federal Air Surgeon and were submitted to AST for final consideration and subsequent discussion with COMSTAC on October 26, 2004

• June 1999: The SMPC produced a prioritized list of medical and human factors research needs in support of manned commercial space operations that was submitted to AST

• February 2000: The SMCS produced a final draft on “Recommended Guidelines for Medical Screening of Commercial Space Passengers” that was submitted to the Federal Air Surgeon and AST for review

• March 2003: The “Guidelines” were approved by the Federal Air Surgeon and were submitted to AST for final consideration and subsequent discussion with COMSTAC on October 26, 2004

FAA Office of Aerospace MedicineFAA Office of Aerospace Medicine

Page 19: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

What did we do to medically certify SpaceShipOne test pilots?

What did we do to medically certify SpaceShipOne test pilots?

Page 20: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

We authorized a routine Class 2 Airman Medical Certificate issued by an

Aviation Medical Examiner (AME) and reviewed by the

Aerospace Medical Certification Division at

CAMI

We authorized a routine Class 2 Airman Medical Certificate issued by an

Aviation Medical Examiner (AME) and reviewed by the

Aerospace Medical Certification Division at

CAMI

Page 21: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

“Recommended Guidelines for Medical

Screening of Commercial Space Passengers”

“Recommended Guidelines for Medical

Screening of Commercial Space Passengers”

Page 22: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

What is the minimum “Right Stuff” for passengers in commercial space flights?

What is the minimum “Right Stuff” for passengers in commercial space flights?

Page 23: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

How conservative should medical screening guidelines be for space passengers in order to:

Promote the preservation of life and the safety of the flight?

and at the same time

Avoid imposing an obstacle to the successful establishment and growth of the manned space tourism industry?

How conservative should medical screening guidelines be for space passengers in order to:

Promote the preservation of life and the safety of the flight?

and at the same time

Avoid imposing an obstacle to the successful establishment and growth of the manned space tourism industry?

Page 24: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

“The problem is never how to get new, innovative thoughts into your mind, but how to get the old ones out”

Dee Hock

“The problem is never how to get new, innovative thoughts into your mind, but how to get the old ones out”

Dee Hock

Page 25: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Such guidelines should enable the identification of prospective space passengers who have certain medical conditions that are likely to:• result in in-flight death

• result in a sudden in-flight medical emergency

• compromise in any other way the health and safety of all occupants onboard a commercial space vehicle

Such guidelines should enable the identification of prospective space passengers who have certain medical conditions that are likely to:• result in in-flight death

• result in a sudden in-flight medical emergency

• compromise in any other way the health and safety of all occupants onboard a commercial space vehicle

MEDICAL SCREENING GUIDELINES FOR SPACE PASSENGERS

MEDICAL SCREENING GUIDELINES FOR SPACE PASSENGERS

Page 26: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Main Risk Factors Relevant to the Development of Guidelines for Medical Screening of

Commercial Space Passengers

Main Risk Factors Relevant to the Development of Guidelines for Medical Screening of

Commercial Space Passengers

• Exposure to acceleration/deceleration

• Exposure to decreased barometric pressure

• Exposure to microgravity

• Exposure to radiation (solar and cosmic)

• Exposure to acceleration/deceleration

• Exposure to decreased barometric pressure

• Exposure to microgravity

• Exposure to radiation (solar and cosmic)

Page 27: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

In view of the wide variety of possible approaches to design, produce and operate manned commercial RLVs the guidance for medical screening applies differently to two categories of space passengers:

Passengers on suborbital space flights or exposed to a G-load of up to +3Gz during any phase of the flight.

Passengers on orbital space flights or exposed to a G-load exceeding +3Gz during any phase of the flight.

In view of the wide variety of possible approaches to design, produce and operate manned commercial RLVs the guidance for medical screening applies differently to two categories of space passengers:

Passengers on suborbital space flights or exposed to a G-load of up to +3Gz during any phase of the flight.

Passengers on orbital space flights or exposed to a G-load exceeding +3Gz during any phase of the flight.

Page 28: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Guidance for Medical Screening of Passengers on Suborbital Flights or Exposed to a G-Load of up to +3Gz During any Phase of the Flight.

Guidance for Medical Screening of Passengers on Suborbital Flights or Exposed to a G-Load of up to +3Gz During any Phase of the Flight.

Page 29: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• An in-flight cabin environment with a barometric pressure not exceeding 8,000 ft (10.91 psi), where passengers will not be required to use a pressurized suit

• Passengers will be able to perform an emergency evacuation without assistance

• An in-flight cabin environment with a barometric pressure not exceeding 8,000 ft (10.91 psi), where passengers will not be required to use a pressurized suit

• Passengers will be able to perform an emergency evacuation without assistance

This medical screening guidance is based on the following assumptions:This medical screening guidance is based on the following assumptions:

Page 30: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

1. Passengers complete a medical history questionnaire prior to every flight (single or multiple)

2. A company physician who is experienced or trained in the concepts of aerospace medicine reviews the completed questionnaire

3. Passengers do not need to undergo a physical examination nor to complete medical laboratory testing unless deemed necessary by the company physician upon review of the completed questionnaire

1. Passengers complete a medical history questionnaire prior to every flight (single or multiple)

2. A company physician who is experienced or trained in the concepts of aerospace medicine reviews the completed questionnaire

3. Passengers do not need to undergo a physical examination nor to complete medical laboratory testing unless deemed necessary by the company physician upon review of the completed questionnaire

A Common Sense Approach

Page 31: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Recommended Medical History Questionnaire for Suborbital Space

Passengers

Recommended Medical History Questionnaire for Suborbital Space

Passengers• Otitis, sinusitis, bronchitis, asthma, or other respiratory disorders• Dizziness or vertigo• Fainting spells, or any other loss of consciousness• Seizures• Tuberculosis• Surgery and other hospital admissions• Visits to physicians in the last 3 years• Recent significant trauma• History of decompression syndrome (DCS)• Anemia or other blood disorders

• Otitis, sinusitis, bronchitis, asthma, or other respiratory disorders• Dizziness or vertigo• Fainting spells, or any other loss of consciousness• Seizures• Tuberculosis• Surgery and other hospital admissions• Visits to physicians in the last 3 years• Recent significant trauma• History of decompression syndrome (DCS)• Anemia or other blood disorders

Page 32: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• Heart or circulatory disorders, including implanted pacemaker or defibrillator

• Mental disorders• Claustrophobia• Attempted suicide• Use of medications• Alcohol or drug dependence or abuse• Date of last menstrual period, current pregnancy, recent post-

partum (less than 6 weeks), or recent spontaneous or voluntary termination of pregnancy

• Diabetes• Cancer• Rejection for life or health insurance

• Heart or circulatory disorders, including implanted pacemaker or defibrillator

• Mental disorders• Claustrophobia• Attempted suicide• Use of medications• Alcohol or drug dependence or abuse• Date of last menstrual period, current pregnancy, recent post-

partum (less than 6 weeks), or recent spontaneous or voluntary termination of pregnancy

• Diabetes• Cancer• Rejection for life or health insurance

Page 33: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Any deformities (congenital or acquired), diseases, illnesses, injuries, infections, tumors, treatments (pharmacological, surgical, prosthetic, or other), or other physiological or pathological conditions that may:

Any deformities (congenital or acquired), diseases, illnesses, injuries, infections, tumors, treatments (pharmacological, surgical, prosthetic, or other), or other physiological or pathological conditions that may:

Medical Conditions that may Contraindicate Passenger Participation in Suborbital FlightsMedical Conditions that may Contraindicate Passenger Participation in Suborbital Flights

1) Result in an in-flight death2) Result in an in-flight medical emergency3) Interfere with the proper use (don and doff) and operation of personal

protective equipment4) Interfere with in-flight emergency procedures or emergency evacuation5) Compromise the health and safety of the passenger or other space

vehicle occupants, and/or the safety of the flight

1) Result in an in-flight death2) Result in an in-flight medical emergency3) Interfere with the proper use (don and doff) and operation of personal

protective equipment4) Interfere with in-flight emergency procedures or emergency evacuation5) Compromise the health and safety of the passenger or other space

vehicle occupants, and/or the safety of the flight

Page 34: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

An established clinical diagnosis or finding of any of the following conditions may contraindicate participation in space flight and

should be evaluated on a case-by-case basis:

An established clinical diagnosis or finding of any of the following conditions may contraindicate participation in space flight and

should be evaluated on a case-by-case basis:

• Acute or chronic use of any medication (prescription and/or non-prescription), drug, or substance

• Severe trauma or invasive medical procedures (diagnostic or therapeutic) associated with significant functional deficit

• Severe acute or chronic infections or communicable/contagious diseases (including blood borne infectious diseases)

• Cancer

• Acute or chronic use of any medication (prescription and/or non-prescription), drug, or substance

• Severe trauma or invasive medical procedures (diagnostic or therapeutic) associated with significant functional deficit

• Severe acute or chronic infections or communicable/contagious diseases (including blood borne infectious diseases)

• Cancer

Page 35: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• Any psychiatric, psychological, mental, or behavioral disorder that would cause an individual to become a potential hazard to him/herself or to others.

• Current pregnancy, recent post-partum (less than 6 weeks), or recent spontaneous or voluntary termination of pregnancy

• History of individual exposure to ionizing radiation (single dose or cumulative) that exceeds the maximum exposure limit of 5 mSv in 5 years recommended by the International Commission on Radiological Protection.

• Any other medical conditions that may result in significant functional impairment or that may be aggravated by exposure to the environmental or operational stress factors of space flight.

• Any psychiatric, psychological, mental, or behavioral disorder that would cause an individual to become a potential hazard to him/herself or to others.

• Current pregnancy, recent post-partum (less than 6 weeks), or recent spontaneous or voluntary termination of pregnancy

• History of individual exposure to ionizing radiation (single dose or cumulative) that exceeds the maximum exposure limit of 5 mSv in 5 years recommended by the International Commission on Radiological Protection.

• Any other medical conditions that may result in significant functional impairment or that may be aggravated by exposure to the environmental or operational stress factors of space flight.

Page 36: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Suggested handling of prospective space passengers who have medical conditions that

may contraindicate participation in space flight:

Suggested handling of prospective space passengers who have medical conditions that

may contraindicate participation in space flight:

• These individuals could be given medical clearance on a case-by-case basis by the company physician

• Based on the specific nature of the medical condition, an individual could be temporarily prohibited from participation in space flight until such a condition resolves or until it can be effectively brought under medical control

• These individuals could be given medical clearance on a case-by-case basis by the company physician

• Based on the specific nature of the medical condition, an individual could be temporarily prohibited from participation in space flight until such a condition resolves or until it can be effectively brought under medical control

Page 37: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

• Prospective passengers should be informed on the potential hazards to health of space flight, including the hazards of exposure to solar and cosmic radiation, acceleration, and microgravity

• It must also be recognized that no conclusive data exist concerning the potential adverse physiologic and pathologic effects of space flight on infants or young children. For this reason, operators may wish to establish a minimum age for passengers participating in space flights.

• Prospective passengers should be informed on the potential hazards to health of space flight, including the hazards of exposure to solar and cosmic radiation, acceleration, and microgravity

• It must also be recognized that no conclusive data exist concerning the potential adverse physiologic and pathologic effects of space flight on infants or young children. For this reason, operators may wish to establish a minimum age for passengers participating in space flights.

Other ConsiderationsOther Considerations

Page 38: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

1) EXTERNAL ENVIRONMENTAL FACTORS

2) OPERATIONAL FACTORS (Vehicle and Flight Operations)

3) INDIVIDUAL FACTORS

1) EXTERNAL ENVIRONMENTAL FACTORS

2) OPERATIONAL FACTORS (Vehicle and Flight Operations)

3) INDIVIDUAL FACTORS

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 39: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

1) EXTERNAL ENVIRONMENTAL FACTORS:- Weather (during the atmospheric phase of flight)

- Barometric pressure

- Ambient temperature

- Solar and cosmic radiation

- Microgravity/weightlessness

- Space debris (natural and human-made)

- Post-emergency landing or post-crash survival issues

1) EXTERNAL ENVIRONMENTAL FACTORS:- Weather (during the atmospheric phase of flight)

- Barometric pressure

- Ambient temperature

- Solar and cosmic radiation

- Microgravity/weightlessness

- Space debris (natural and human-made)

- Post-emergency landing or post-crash survival issues

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 40: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 41: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

Largest solar super flare on record occurredat 21:51 pm on Monday, April 2, 2001

Largest solar super flare on record occurredat 21:51 pm on Monday, April 2, 2001

Short exposures in suborbital flightsShort exposures in suborbital flights

Page 42: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

But then several even larger solar superflares occurredon November 2003

But then several even larger solar superflares occurredon November 2003

Longer exposures in suborbital flightsLonger exposures in suborbital flights

Page 43: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 44: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 45: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

A speck of paint from a satellite dug a pit in a space shuttle window nearly ¼ inch wide

NASA has replaced more than 80 shuttle windows due to debris impacts

A speck of paint from a satellite dug a pit in a space shuttle window nearly ¼ inch wide

NASA has replaced more than 80 shuttle windows due to debris impacts

Space debris will be a risk factor for the occupants of

orbital space vehicles

Page 46: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

January 1997 – A 580 pound tank from the 2nd stage of a Delta 2 survived reentry and crashed in Georgetown, Texas

January 2001 – A 140 pound payload assist module of a Delta 2 crashed in Saudi Arabia

January 1997 – A 580 pound tank from the 2nd stage of a Delta 2 survived reentry and crashed in Georgetown, Texas

January 2001 – A 140 pound payload assist module of a Delta 2 crashed in Saudi Arabia

Space debris is a concern for the safety of people on the ground

Space debris is a concern for the safety of people on the ground

Page 47: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 48: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

2) OPERATIONAL FACTORS (Vehicle and Flight Operations):

- Type of acceleration profile (take off/launch, cruise, landing) and relative position of the occupants during acceleration exposure

- Type of flight profile (ascent rate, maximum altitude, descent rate, duration of the flight)

- Cabin/suit pressurization profile

- Noise/vibration exposure during flight

2) OPERATIONAL FACTORS (Vehicle and Flight Operations):

- Type of acceleration profile (take off/launch, cruise, landing) and relative position of the occupants during acceleration exposure

- Type of flight profile (ascent rate, maximum altitude, descent rate, duration of the flight)

- Cabin/suit pressurization profile

- Noise/vibration exposure during flight

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 49: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

SpaceShipOne test pilots did not use pressure suitsSpaceShipOne test pilots did not use pressure suits

Page 50: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

2) OPERATIONAL FACTORS (Vehicle and Flight Operations):

- Breathing air (composition, contaminants, CO2 removal, volume per occupant)

- Cabin/suit temperature and humidity

- Impact/crash exposure (structural integrity or crashworthiness, occupant restraint systems, personal protective equipment, emergency evacuation systems, etc.)

2) OPERATIONAL FACTORS (Vehicle and Flight Operations):

- Breathing air (composition, contaminants, CO2 removal, volume per occupant)

- Cabin/suit temperature and humidity

- Impact/crash exposure (structural integrity or crashworthiness, occupant restraint systems, personal protective equipment, emergency evacuation systems, etc.)

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 51: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 52: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 53: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 54: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 55: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 56: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 57: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

2) OPERATIONAL FACTORS (Vehicle and Flight Operations):

- Physical hazards (electrical, chemical, thermal) of the cabin

- Injuries due to accidental contact with internal structures or objects especially during microgravity

- Inflight fire (fire retardant materials, toxic materials, fire suppression systems)

2) OPERATIONAL FACTORS (Vehicle and Flight Operations):

- Physical hazards (electrical, chemical, thermal) of the cabin

- Injuries due to accidental contact with internal structures or objects especially during microgravity

- Inflight fire (fire retardant materials, toxic materials, fire suppression systems)

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 58: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 59: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

3) INDIVIDUAL FACTORS:- Unidentified or undisclosed pre-existing medical

conditions

- Unexpected inflight medical emergencies (acute illnesses or trauma)

- Self-imposed stress (alcohol and drug use/abuse, nicotine addiction, self-medication, fatigue, dehydration, poor fitness, extreme overweight)

3) INDIVIDUAL FACTORS:- Unidentified or undisclosed pre-existing medical

conditions

- Unexpected inflight medical emergencies (acute illnesses or trauma)

- Self-imposed stress (alcohol and drug use/abuse, nicotine addiction, self-medication, fatigue, dehydration, poor fitness, extreme overweight)

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 60: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.

3) INDIVIDUAL FACTORS:- Space motion sickness

- Unknown or undisclosed pregnancy

- Undisclosed use of medications

- Disruptive passengers

3) INDIVIDUAL FACTORS:- Space motion sickness

- Unknown or undisclosed pregnancy

- Undisclosed use of medications

- Disruptive passengers

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

RISK FACTORS FOR THE OCCUPANTS OF SPACE VEHICLES

Page 61: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.
Page 62: Medical Considerations for Manned Commercial Space Flight Melchor Antuñano, M.D., M.S. Director, FAA Civil Aerospace Medical Institute Medical Considerations.